{"id":13709,"date":"2013-12-03T15:36:55","date_gmt":"2013-12-03T14:36:55","guid":{"rendered":"http:\/\/www.invarena.cz\/?p=13709"},"modified":"2013-12-03T15:37:34","modified_gmt":"2013-12-03T14:37:34","slug":"vzp-hradi-zenam-s-rakovinou-prsu-test-zda-chemoterapii-ano-ci-ne","status":"publish","type":"post","link":"https:\/\/www.invarena.cz\/?p=13709","title":{"rendered":"VZP za\u010dala hradit \u017een\u00e1m s rakovinou prsu test, zda chemoterapii ano \u010di ne"},"content":{"rendered":"

V\u0161eobecn\u00e1 zdravotn\u00ed poji\u0161\u0165ovna za\u010dala hradit \u017een\u00e1m s rakovinou prsu speci\u00e1ln\u00ed genetick\u00fd test, jen\u017e zjist\u00ed, zda pacientce chemoterapie pom\u016f\u017ee nebo zda jde o typ rakoviny, na kter\u00fd chemoterapie nezap\u016fsob\u00ed.\u00a0 Vyhnou se tak zbyte\u010dn\u00e9\u00a0 l\u00e9\u010db\u011b chemick\u00fdmi prepar\u00e1ty.<\/strong><\/p>\n

Test Oncotype DX rozli\u0161\u00ed mezi pacientkami, kter\u00fdm chemoterapie pom\u016f\u017ee, a t\u011bmi, pro n\u011b\u017e by znamenala zbyte\u010dnou z\u00e1t\u011b\u017e a riziko n\u00e1vratu rakoviny by nesn\u00ed\u017eila. Novin\u00e1\u0159\u016fm to \u0159ekl n\u00e1m\u011bstek \u0159editele VZP Petr Hon\u011bk s t\u00edm, \u017ee VZP hrad\u00ed test jako prvn\u00ed a zat\u00edm jedin\u00e1 v \u010cR.<\/p>\n

Test pom\u016f\u017ee l\u00e9ka\u0159\u016fm p\u0159i rozhodov\u00e1n\u00ed, jakou l\u00e9\u010dbu volit. VZP ho bude hradit pouze v komplexn\u00edch onkologick\u00fdch centrech, kter\u00fdch je v \u010cR 14. Mohou ho vyu\u017e\u00edt u pacientek se zhoubn\u00fdm n\u00e1dorem prsu, kter\u00e9 nemaj\u00ed zasa\u017eeny podpa\u017en\u00ed uzliny.<\/p>\n

Pokud u nich vznik n\u00e1doru souvis\u00ed s hormony, podstupuj\u00ed po operaci hormon\u00e1ln\u00ed l\u00e9\u010dbu. Pro pos\u00edlen\u00ed \u00fa\u010dinku se p\u0159id\u00e1v\u00e1 chemoterapie, u zhruba p\u011bti procent t\u011bchto pacientek ale nen\u00ed z dostupn\u00fdch vy\u0161et\u0159en\u00ed jasn\u00e9, zda chemoterapie zabere. To pom\u016f\u017ee rozli\u0161it nov\u00fd test.<\/p>\n

L\u00e9ka\u0159i po\u0161lou vzorek tk\u00e1n\u011b odebran\u00e9 p\u0159i operaci do centr\u00e1ln\u00ed laborato\u0159e v USA, kter\u00e1 prov\u00e1d\u00ed jako jedin\u00e1 testy pro cel\u00fd sv\u011bt a m\u00e1 s t\u00edm zku\u0161enosti – k 30. \u010dervnu provedla pro 19.000 l\u00e9ka\u0159\u016f ze 70 zem\u00ed p\u0159es 375.000 t\u011bchto test\u016f.<\/p>\n

V\u00fdsledky testu jsou zn\u00e1my za sedm a\u017e deset dn\u016f. U pacientky stanov\u00ed tzv. sk\u00f3re recidivy, tedy riziko n\u00e1vratu zhoubn\u00e9 nemoci od nuly do sta. Do 18 je riziko n\u00edzk\u00e9, od 30 vysok\u00e9. Testy umo\u017en\u00ed rozhodnout u zhruba dvou t\u0159etin z p\u011bti procent pacientek, u nich\u017e zat\u00edm l\u00e9ka\u0159i vod\u00edtko nem\u011bli.<\/p>\n

VZP uhradila testy dosud 13 pacientk\u00e1m brn\u011bnsk\u00e9ho Masarykova onkologick\u00e9ho \u00fastavu, jen u jedn\u00e9 uk\u00e1zaly riziko tak vysok\u00e9, \u017ee musela podstoupit chemoterapii. Ostatn\u00edch 12 pacientek se bez n\u00ed obe\u0161lo a vyhnulo se tak n\u00e1sledk\u016fm chemoterapie, jako je vypad\u00e1n\u00ed vlas\u016f \u010di dlouhodob\u00e9 po\u0161kozen\u00ed srdce.<\/p>\n

Za akutn\u00ed chemoterapii plat\u00ed VZP 120.000 korun, s \u00fahradou pozdn\u00edch komplikac\u00ed \u010d\u00e1stka roste.<\/p>\n

VZP za jeden test d\u00e1 98.000 korun, podle Ho\u0148ka si VZP spo\u010d\u00edtala, \u017ee testov\u00e1n\u00ed je pro n\u00ed „n\u00e1kladov\u011b efektivn\u00ed“.<\/p>\n

Test je v \u010cR dostupn\u00fd u\u017e zhruba dva roky, zat\u00edm si ho ale \u017eeny musely platit samy. Zhruba deset si ho opravdu zaplatilo.<\/p>\n

Ro\u010dn\u011b se v \u010cR zjist\u00ed rakovina prsu u 6000 \u017een, zem\u0159ou 2000. Loni na ve\u0161kerou p\u00e9\u010di spojenou s l\u00e9\u010dbou rakoviny prsu vydala VZP p\u0159es dv\u011b miliardy korun. Test podle Ho\u0148ka m\u016f\u017ee p\u0159in\u00e9st \u00faspory ro\u010dn\u011b v des\u00edtk\u00e1ch milion\u016f korun, hlavn\u011b ale bude p\u0159\u00ednosem pro kvalitu \u017eivota pacientek, kter\u00e9 nebudou muset zbyte\u010dn\u011b podstupovat chemoterapii.<\/p>\n","protected":false},"excerpt":{"rendered":"

V\u0161eobecn\u00e1 zdravotn\u00ed poji\u0161\u0165ovna za\u010dala hradit \u017een\u00e1m s rakovinou prsu speci\u00e1ln\u00ed genetick\u00fd test, jen\u017e zjist\u00ed, zda pacientce chemoterapie pom\u016f\u017ee nebo zda jde o typ rakoviny, na […]<\/a><\/p>\n<\/div>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-13709","post","type-post","status-publish","format-standard","hentry","category-zdravi"],"_links":{"self":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts\/13709","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13709"}],"version-history":[{"count":0,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts\/13709\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13709"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13709"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13709"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}